黄山胶囊收盘上涨1.12%，滚动市盈率40.87倍，总市值21.56亿元

Core Viewpoint - Huangshan Capsule's stock closed at 7.21 yuan, up 1.12%, with a rolling PE ratio of 40.87, marking a new low in 103 days, and a total market value of 2.156 billion yuan [1][2] Company Overview - Anhui Huangshan Capsule Co., Ltd. specializes in the research, production, and sales of gelatin hollow capsules and enteric-coated gelatin hollow capsules, being one of the earliest manufacturers in China with over 30 years of high-quality production history [1] - The company has a strong reputation in the pharmaceutical hollow capsule industry and is a member of the China Pharmaceutical Packaging Association, recognized for its contributions [1] Financial Performance - In Q1 2025, the company achieved an operating income of 119 million yuan, a year-on-year increase of 0.53%, and a net profit of 18.837 million yuan, up 22.90% year-on-year, with a gross profit margin of 29.26% [2] Market Position - Huangshan Capsule ranks 84th in the medical device industry based on PE ratio, with the industry average at 49.51 and the median at 36.17 [1][2] - The average PE ratio for the industry is significantly higher than Huangshan Capsule's current PE ratio, indicating potential undervaluation [2]